{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:59:46Z","timestamp":1794373186122,"version":"4.9.0"},"reference-count":58,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>CCAAT enhancer-binding protein (CEBP) transcription factors play pivotal roles in proliferation and differentiation, including suppression of myeloid leukemogenesis. Mutations of CEBPA are found in a subset of acute myeloid leukemia (AML) and in some cases of familial AML. Here, using cytogenetics, fluorescence in situ hybridization (FISH), and molecular cloning, we show that 5 CEBP gene family members are targeted by recurrent IGH chromosomal translocations in BCP-ALL. Ten patients with t(8;14)(q11;q32) involved CEBPD on chromosome 8, and 9 patients with t(14;19)(q32;q13) involved CEBPA, while a further patient involved CEBPG, located 71 kb telomeric of CEBPA in chromosome band 19q13; 4 patients with inv(14)(q11q32)\/t(14;14)(q11;q32) involved CEBPE and 3 patients with t(14;20)(q32;q13) involved CEBPB. In 16 patients the translocation breakpoints were cloned using long-distance inverse\u2013polymerase chain reaction (LDI-PCR). With the exception of CEBPD breakpoints, which were scattered within a 43-kb region centromeric of CEBPD, translocation breakpoints were clustered immediately 5\u2032 or 3\u2032 of the involved CEBP gene. Except in 1 patient with t(14;14)(q11;q32), the involved CEBP genes retained germ-line sequences. Quantitative reverse transcription (RT)\u2013PCR showed overexpression of the translocated CEBP gene. Our findings implicate the CEBP gene family as novel oncogenes in BCP-ALL, and suggest opposing functions of CEBP dysregulation in myeloid and lymphoid leukemogenesis.<\/jats:p>","DOI":"10.1182\/blood-2006-08-041012","type":"journal-article","created":{"date-parts":[[2006,12,15]],"date-time":"2006-12-15T01:54:05Z","timestamp":1166147645000},"page":"3451-3461","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":183,"title":["Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)"],"prefix":"10.1182","volume":"109","author":[{"given":"Takashi","family":"Akasaka","sequence":"first","affiliation":[{"name":"Medical Research Council (MRC) Toxicology Unit, University of Leicester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Balasas","sequence":"additional","affiliation":[{"name":"Medical Research Council (MRC) Toxicology Unit, University of Leicester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa J.","family":"Russell","sequence":"additional","affiliation":[{"name":"Leukaemia Research Cytogenetics Group, Cancer Sciences Division, University of Southampton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei-ji","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Medical Research Council (MRC) Toxicology Unit, University of Leicester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneela","family":"Majid","sequence":"additional","affiliation":[{"name":"Medical Research Council (MRC) Toxicology Unit, University of Leicester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Walewska","sequence":"additional","affiliation":[{"name":"Medical Research Council (MRC) Toxicology Unit, University of Leicester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Loraine","family":"Karran","sequence":"additional","affiliation":[{"name":"Medical Research Council (MRC) Toxicology Unit, University of Leicester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Brown","sequence":"additional","affiliation":[{"name":"Medical Research Council (MRC) Toxicology Unit, University of Leicester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin","family":"Cain","sequence":"additional","affiliation":[{"name":"Medical Research Council (MRC) Toxicology Unit, University of Leicester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana","family":"Harder","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, University Hospital Schleswig-Holstein, Campus Kiel, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gesk","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, University Hospital Schleswig-Holstein, Campus Kiel, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Ignacio","family":"Martin-Subero","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, University Hospital Schleswig-Holstein, Campus Kiel, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Atherton","sequence":"additional","affiliation":[{"name":"Merseyside & Cheshire Genetics Laboratory, Liverpool Women's Hospital, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Bru\u0308ggemann","sequence":"additional","affiliation":[{"name":"Second Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u0301a Jose\u0301","family":"Calasanz","sequence":"additional","affiliation":[{"name":"Departamento de Gene\u0301tica, Universidad de Navarra, Pamplona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Davies","sequence":"additional","affiliation":[{"name":"South West Regional Cytogenetics Centre, Southmead Hospital, Bristol, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar A.","family":"Haas","sequence":"additional","affiliation":[{"name":"Children's Cancer Research Institute, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Hagemeijer","sequence":"additional","affiliation":[{"name":"Center for Human Genetics, Leuven, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Kempski","sequence":"additional","affiliation":[{"name":"Paediatric Malignancy Cytogenetics Laboratory, Great Ormond Street Hospital for Sick Children, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Lessard","sequence":"additional","affiliation":[{"name":"Laboratoire d'He\u0301matologie, Ho\u0302pital de Hautepierre, Strasbourg, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra M.","family":"Lillington","sequence":"additional","affiliation":[{"name":"Cancer Research UK Medical Oncology Unit, St Bartholomew's Hospital Medical School, Queen Mary University of London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Moore","sequence":"additional","affiliation":[{"name":"South Australia Cancer Cytogenetics Unit, Institute of Medical and Veterinary Science, Adelaide, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Nguyen-Khac","sequence":"additional","affiliation":[{"name":"Unite\u0301 de Cytoge\u0301ne\u0301tique He\u0301matologique, EO210 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Groupe Hospitalier Pitie\u0301-Salpetriere, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Radford-Weiss","sequence":"additional","affiliation":[{"name":"Unite\u0301 de Cytoge\u0301ne\u0301tique He\u0301matologique, Service d'Histo-Embryologie et de Cytoge\u0301ne\u0301tique, Ho\u0302pital Necker\u2013Enfants Malades, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Schoch","sequence":"additional","affiliation":[{"name":"MLL Mu\u0308nchner Leuka\u0308mielabor, Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ste\u0301phanie","family":"Struski","sequence":"additional","affiliation":[{"name":"Laboratoire d'He\u0301matologie, Ho\u0302pital de Hautepierre, Strasbourg, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polly","family":"Talley","sequence":"additional","affiliation":[{"name":"Sheffield Regional Cytogenetics Service, Sheffield Children's Hospital, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie J.","family":"Welham","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Pharmacology, University of Bath, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Worley","sequence":"additional","affiliation":[{"name":"Leukaemia Research Cytogenetics Group, Cancer Sciences Division, University of Southampton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon C.","family":"Strefford","sequence":"additional","affiliation":[{"name":"Leukaemia Research Cytogenetics Group, Cancer Sciences Division, University of Southampton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine J.","family":"Harrison","sequence":"additional","affiliation":[{"name":"Leukaemia Research Cytogenetics Group, Cancer Sciences Division, University of Southampton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Siebert","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, University Hospital Schleswig-Holstein, Campus Kiel, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J. S.","family":"Dyer","sequence":"additional","affiliation":[{"name":"Medical Research Council (MRC) Toxicology Unit, University of Leicester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2006,12,14]]},"reference":[{"key":"2019111712350548400_B1","doi-asserted-by":"crossref","unstructured":"Tenen DG. Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer2003; 3:89\u2013101.","DOI":"10.1038\/nrc989"},{"key":"2019111712350548400_B2","doi-asserted-by":"crossref","unstructured":"Lekstrom-Himes J and Xanthopoulos KG. Biological role of the CCAAT\/enhancer-binding protein family of transcription factors. J Biol Chem1998; 273:28545\u201328548.","DOI":"10.1074\/jbc.273.44.28545"},{"key":"2019111712350548400_B3","doi-asserted-by":"crossref","unstructured":"Nerlov C. C\/EBPalpha mutations in acute myeloid leukaemias. Nat Rev Cancer2004; 4:394\u2013400.","DOI":"10.1038\/nrc1363"},{"key":"2019111712350548400_B4","doi-asserted-by":"crossref","unstructured":"Lekstrom-Himes JA, Dorman SE, Kopar P, Holland SM, Gallin JI. Neutrophil-specific granule deficiency results from a novel mutation with loss of function of the transcription factor CCAAT\/enhancer binding protein epsilon. J Exp Med1999; 189:1847\u20131852.","DOI":"10.1084\/jem.189.11.1847"},{"key":"2019111712350548400_B5","doi-asserted-by":"crossref","unstructured":"Gombart AF, Shiohara M, Kwok SH, Agematsu K, Komiyama A, Koeffler HP. Neutrophil-specific granule deficiency: homozygous recessive inheritance of a frameshift mutation in the gene encoding transcription factor CCAAT\/enhancer binding protein-epsilon. Blood2001; 97:2561\u20132567.","DOI":"10.1182\/blood.V97.9.2561"},{"key":"2019111712350548400_B6","doi-asserted-by":"crossref","unstructured":"Ossipow V, Descombes P, Schibler U. CCAAT\/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc Natl Acad Sci U S A1993; 90:8219\u20138223.","DOI":"10.1073\/pnas.90.17.8219"},{"key":"2019111712350548400_B7","doi-asserted-by":"crossref","unstructured":"Yamanaka R, Kim GD, Radomska HS, et al. CCAAT\/enhancer binding protein epsilon is preferentially up-regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing. Proc Natl Acad Sci U S A1997; 94:6462\u20136467.","DOI":"10.1073\/pnas.94.12.6462"},{"key":"2019111712350548400_B8","doi-asserted-by":"crossref","unstructured":"Calkhoven CF, Muller C, Leutz A. Translational control of C\/EBPalpha and C\/EBPbeta isoform expression. Genes Dev2000; 14:1920\u20131932.","DOI":"10.1101\/gad.14.15.1920"},{"key":"2019111712350548400_B9","doi-asserted-by":"crossref","unstructured":"Cooper C, Henderson A, Artandi S, Avitahl N, Calame K. Ig\/EBP (C\/EBP gamma) is a transdominant negative inhibitor of C\/EBP family transcriptional activators. Nucleic Acids Res1995; 23:4371\u20134377.","DOI":"10.1093\/nar\/23.21.4371"},{"key":"2019111712350548400_B10","doi-asserted-by":"crossref","unstructured":"Parkin SE, Baer M, Copeland TD, Schwartz RC, Johnson PF. Regulation of CCAAT\/enhancer-binding protein (C\/EBP) activator proteins by heterodimerization with C\/EBPgamma (Ig\/EBP). J Biol Chem2002; 277:23563\u201323572.","DOI":"10.1074\/jbc.M202184200"},{"key":"2019111712350548400_B11","doi-asserted-by":"crossref","unstructured":"Yamanaka R, Barlow C, Lekstrom-Himes J, et al. Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT\/enhancer binding protein epsilon-deficient mice. Proc Natl Acad Sci U S A1997; 94:13187\u201313192.","DOI":"10.1073\/pnas.94.24.13187"},{"key":"2019111712350548400_B12","doi-asserted-by":"crossref","unstructured":"Johnson PF. Molecular stop signs: regulation of cell-cycle arrest by C\/EBP transcription factors. J Cell Sci2005; 118:2545\u20132555.","DOI":"10.1242\/jcs.02459"},{"key":"2019111712350548400_B13","doi-asserted-by":"crossref","unstructured":"Zhang DE, Zhang P, Wang ND, Hetherington CJ, Darlington GJ, Tenen DG. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci U S A1997; 94:569\u2013574.","DOI":"10.1073\/pnas.94.2.569"},{"key":"2019111712350548400_B14","doi-asserted-by":"crossref","unstructured":"Heavey B, Charalambous C, Cobaleda C, Busslinger M. Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C\/EBPalpha and GATA factors. EMBO J2003; 22:3887\u20133897.","DOI":"10.1093\/emboj\/cdg380"},{"key":"2019111712350548400_B15","doi-asserted-by":"crossref","unstructured":"Xie H, Ye M, Feng R, Graf T. Stepwise reprogramming of B cells into macrophages. Cell2004; 117:663\u2013676.","DOI":"10.1016\/S0092-8674(04)00419-2"},{"key":"2019111712350548400_B16","doi-asserted-by":"crossref","unstructured":"Pabst T, Mueller BU, Zhang P, et al. Dominant-negative mutations of CEBPA, encoding CCAAT\/enhancer binding protein-alpha (C\/EBPalpha), in acute myeloid leukemia. Nat Genet2001; 27:263\u2013270.","DOI":"10.1038\/85820"},{"key":"2019111712350548400_B17","doi-asserted-by":"crossref","unstructured":"Smith ML, Cavenagh JD, Lister TA, Fitzgibbon J. Mutation of CEBPA in familial acute myeloid leukemia. N Engl J Med2004; 351:2403\u20132407.","DOI":"10.1056\/NEJMoa041331"},{"key":"2019111712350548400_B18","doi-asserted-by":"crossref","unstructured":"Preudhomme C, Sagot C, Boissel N, et al. Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA). Blood2002; 100:2717\u20132723.","DOI":"10.1182\/blood-2002-03-0990"},{"key":"2019111712350548400_B19","doi-asserted-by":"crossref","unstructured":"Frohling S, Schlenk RF, Stolze I, et al. CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations. J Clin Oncol2004; 22:624\u2013633.","DOI":"10.1200\/JCO.2004.06.060"},{"key":"2019111712350548400_B20","doi-asserted-by":"crossref","unstructured":"Fitzgibbon J, Smith LL, Raghavan M, et al. Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias. Cancer Res2005; 65:9152\u20139154.","DOI":"10.1158\/0008-5472.CAN-05-2017"},{"key":"2019111712350548400_B21","doi-asserted-by":"crossref","unstructured":"Guerzoni C, Bardini M, Mariani SA, et al. Inducible activation of CEBPB, a gene negatively regulated by BCR\/ABL, inhibits proliferation and promotes differentiation of BCR\/ABL-expressing cells. Blood2006; 107:4080\u20134089.","DOI":"10.1182\/blood-2005-08-3181"},{"key":"2019111712350548400_B22","doi-asserted-by":"crossref","unstructured":"Helbling D, Mueller BU, Timichenko NA, et al. The leukemic fusion gene AML1-MDS-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of calreticulin. Proc Natl Acad Sci USA2004; 101:13312\u201313317.","DOI":"10.1073\/pnas.0404731101"},{"key":"2019111712350548400_B23","doi-asserted-by":"crossref","unstructured":"Pabst T, Mueller BU, Harakawa N, et al. AML1-ETO downregulates the granulocytic differentiation factor C\/EBP\u03b1 in t(8;21) myeloid leukemia. Nat Med2001; 7:444\u2013451.","DOI":"10.1038\/86515"},{"key":"2019111712350548400_B24","doi-asserted-by":"crossref","unstructured":"Radomska HS, Basseres DS, Zheng R, et al. Block of C\/EBP alpha function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations. J Exp Med2006; 203:371\u2013381.","DOI":"10.1084\/jem.20052242"},{"key":"2019111712350548400_B25","doi-asserted-by":"crossref","unstructured":"Laiosa CV, Stadtfeld M, Graf T. Determinants of lymphoid-myeloid lineage diversification. Annu Rev Immunol2006; 24:705\u2013738.","DOI":"10.1146\/annurev.immunol.24.021605.090742"},{"key":"2019111712350548400_B26","doi-asserted-by":"crossref","unstructured":"Fine BM, Stanulla M, Schrappe M, et al. Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia. Blood2004; 103:1043\u20131049.","DOI":"10.1182\/blood-2003-05-1518"},{"key":"2019111712350548400_B27","doi-asserted-by":"crossref","unstructured":"Harashima A, Matsuo Y, Drexler HG, et al. Transcription factor expression in B-cell precursor-leukemia cell lines: preferential expression of T-bet. Leuk Res2005; 29:841\u2013848.","DOI":"10.1016\/j.leukres.2004.12.010"},{"key":"2019111712350548400_B28","doi-asserted-by":"crossref","unstructured":"Heckman CA, Wheeler MA, Boxer LM. Regulation of Bcl-2 expression by C\/EBP in t(14;18) lymphoma cells. Oncogene2003; 22:7891\u20137899.","DOI":"10.1038\/sj.onc.1206639"},{"key":"2019111712350548400_B29","doi-asserted-by":"crossref","unstructured":"Leroy H, Roumier C, Huyghe P, Biggio V, Fenaux P, Preudhomme C. CEBPA point mutations in hematological malignancies. Leukemia2005; 19:329\u2013334.","DOI":"10.1038\/sj.leu.2403614"},{"key":"2019111712350548400_B30","doi-asserted-by":"crossref","unstructured":"Willis TG and Dyer MJ. The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood2000; 96:808\u2013822.","DOI":"10.1182\/blood.V96.3.808"},{"key":"2019111712350548400_B31","doi-asserted-by":"crossref","unstructured":"Meeker TC, Hardy D, Willman C, Hogan T, Abrams J. Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia. Blood1990; 76:285\u2013289.","DOI":"10.1182\/blood.V76.2.285.bloodjournal762285"},{"key":"2019111712350548400_B32","doi-asserted-by":"crossref","unstructured":"Willis TG, Zalcberg IR, Coignet LJ, et al. Molecular cloning of translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21. Blood1998; 91:1873\u20131881.","DOI":"10.1182\/blood.V91.6.1873.1873_1873_1881"},{"key":"2019111712350548400_B33","doi-asserted-by":"crossref","unstructured":"Kawamata N, Sakajiri S, Sugimoto KJ, Isobe Y, Kobayashi H, Oshimi K. A novel chromosomal translocation t(1;14)(q25;q32) in pre-B acute lymphoblastic leukemia involves the LIM homeodomain protein gene, Lhx4. Oncogene2002; 21:4983\u20134991.","DOI":"10.1038\/sj.onc.1205628"},{"key":"2019111712350548400_B34","unstructured":"Bellido M, Aventin A, Lasa A, et al. Id4 is deregulated by a t(6;14)(p22;q32) chromosomal translocation in a B-cell lineage acute lymphoblastic leukemia. Haematologica2003; 88:994\u20131001."},{"key":"2019111712350548400_B35","doi-asserted-by":"crossref","unstructured":"Sonoki T, Iwanaga E, Mitsuya H, Asou N. Insertion of microRNA-125b-1, a human homologue of lin-4, into a rearranged immunoglobulin heavy chain gene locus in a patient with precursor B-cell acute lymphoblastic leukemia. Leukemia2005; 19:2009\u20132010.","DOI":"10.1038\/sj.leu.2403938"},{"key":"2019111712350548400_B36","doi-asserted-by":"crossref","unstructured":"Kaleem Z, Shuster JJ, Carroll AJ, et al. Acute lymphoblastic leukemia with an unusual t(8;14)(q11.2;q32): a Pediatric Oncology Group Study. Leukemia2000; 14:238\u2013240.","DOI":"10.1038\/sj.leu.2401675"},{"key":"2019111712350548400_B37","doi-asserted-by":"crossref","unstructured":"Byatt SA, Cheung KL, Lillington DM, et al. Three further cases of t(8;14)(q11.2;q32) in acute lymphoblastic leukemia. Leukemia2001; 15:1304\u20131305.","DOI":"10.1038\/sj.leu.2402166"},{"key":"2019111712350548400_B38","doi-asserted-by":"crossref","unstructured":"Robinson HM, Taylor KE, Jalali GR, Cheung KL, Harrison CJ, Moorman AV. t(14;19)(q32;q13): a recurrent translocation in B-cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer2004; 39:88\u201392.","DOI":"10.1002\/gcc.10299"},{"key":"2019111712350548400_B39","doi-asserted-by":"crossref","unstructured":"Moore S, Suttle J, Bain S, Story C, Rice M. Acute lymphoblastic leukemia characterized by t(8;14)(q11.2;q32). Cancer Genet Cytogenet2003; 141:1\u20134.","DOI":"10.1016\/S0165-4608(02)00643-X"},{"key":"2019111712350548400_B40","unstructured":"Akasaka H, Akasaka T, Kurata M, et al. Molecular anatomy of BCL6 translocations revealed by long-distance polymerase chain reaction-based assays. Cancer Res2000; 60:2335\u20132341."},{"key":"2019111712350548400_B41","doi-asserted-by":"crossref","unstructured":"Willis TG, Jadayel DM, Coignet LJ, et al. Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polymerase chain reaction. Blood1997; 90:2456\u20132464.","DOI":"10.1182\/blood.V90.6.2456"},{"key":"2019111712350548400_B42","unstructured":"National Left for Biotechnology Information GenBank database. http:\/\/www.ncbi.nlm.nih.gov\/Genbank Accessed July, 2006."},{"key":"2019111712350548400_B43","unstructured":"University of California Santa Cruz Genome Bioinformatics database. http:\/\/genome.ucsc.edu\/cgi-bin\/hgBlat Accessed July, 2006."},{"key":"2019111712350548400_B44","doi-asserted-by":"crossref","unstructured":"Akasaka T, Akasaka H, Yonetani N, et al. Refinement of the BCL2\/immunoglobulin heavy chain fusion gene in t(14;18)(q32;q21) by polymerase chain reaction amplification for long targets. Genes Chromosomes Cancer1998; 21:17\u201329.","DOI":"10.1002\/(SICI)1098-2264(199801)21:1<17::AID-GCC4>3.0.CO;2-B"},{"key":"2019111712350548400_B45","doi-asserted-by":"crossref","unstructured":"Tartaglia M, Martinelli S, Cazzaniga G, et al. Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia. Blood2004; 104:307\u2013313.","DOI":"10.1182\/blood-2003-11-3876"},{"key":"2019111712350548400_B46","doi-asserted-by":"crossref","unstructured":"Armstrong SA, Mabon ME, Silverman LB, et al. FLT3 mutations in childhood acute lymphoblastic leukemia. Blood2004; 103:3544\u20133546.","DOI":"10.1182\/blood-2003-07-2441"},{"key":"2019111712350548400_B47","doi-asserted-by":"crossref","unstructured":"Lens D, De Schouwer PJ, Hamoudi RA, et al. p53 abnormalities in B-cell prolymphocytic leukemia. Blood1997; 89:2015\u20132023.","DOI":"10.1182\/blood.V89.6.2015"},{"key":"2019111712350548400_B48","doi-asserted-by":"crossref","unstructured":"Twiddy D, Brown DG, Adrain C, et al. Pro-apoptotic proteins released from the mitochondria regulate the protein composition and caspase-processing activity of the native Apaf-1\/caspase-9 apoptosome complex. J Biol Chem2004; 279:19665\u201319682.","DOI":"10.1074\/jbc.M311388200"},{"key":"2019111712350548400_B49","unstructured":"ISCN: An International System for Human Cytogenetic Nomenclature. 2005;In Mitelman F (Ed.). Basel, Switzerland Karger."},{"key":"2019111712350548400_B50","doi-asserted-by":"crossref","unstructured":"Chapiro E, Russell L, Radford-Weiss I, et al. Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia. Blood2006; 108:3560\u20133563.","DOI":"10.1182\/blood-2006-03-010835"},{"key":"2019111712350548400_B51","doi-asserted-by":"crossref","unstructured":"Jung D, Giallourakis C, Mostoslavsky R, Alt FW. Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu Rev Immunol2006; 24:541\u2013570.","DOI":"10.1146\/annurev.immunol.23.021704.115830"},{"key":"2019111712350548400_B52","doi-asserted-by":"crossref","unstructured":"Koralov SB, Novobrantseva TI, Konigsmann J, Ehlich A, Rajewsky K. Antibody repertoires generated by v(h) replacement and direct v(h) to j(h) joining. Immunity2006; 25:43\u201353.","DOI":"10.1016\/j.immuni.2006.04.016"},{"key":"2019111712350548400_B53","doi-asserted-by":"crossref","unstructured":"Salvaris E, Novotny JR, Welch K, Campbell L, Boyd AW. Characterization of two novel pre-B-cell lines (LK63 and LiLa-1): potential models of pre-B-cell differentiation. Leuk Res1992; 16:655\u2013663.","DOI":"10.1016\/0145-2126(92)90016-Z"},{"key":"2019111712350548400_B54","doi-asserted-by":"crossref","unstructured":"Harrison CJ, Martineau M, Secker-Walker LM. The Leukaemia Research Fund\/United Kingdom Cancer Cytogenetics Group Karyotype Database in acute lymphoblastic leukaemia: a valuable resource for patient management. Br J Haematol2001; 113:3\u201310.","DOI":"10.1046\/j.1365-2141.2001.02643.x"},{"key":"2019111712350548400_B55","doi-asserted-by":"crossref","unstructured":"Cilloni D, Carturan S, Gottardi E, et al. Down-modulation of the C\/EBPalpha transcription factor in core binding factor acute myeloid leukemias. Blood2003; 102:2705\u20132706.","DOI":"10.1182\/blood-2003-07-2256"},{"key":"2019111712350548400_B56","doi-asserted-by":"crossref","unstructured":"Shuman JD, Sebastian T, Kaldis P, et al. Cell cycle-dependent phosphorylation of C\/EBPbeta mediates oncogenic cooperativity between C\/EBPbeta and H-RasV12. Mol Cell Biol2004; 24:7380\u20137391.","DOI":"10.1128\/MCB.24.17.7380-7391.2004"},{"key":"2019111712350548400_B57","doi-asserted-by":"crossref","unstructured":"Paz-Priel I, Cai DH, Wang D, et al. CCAAT\/enhancer binding protein a (C\/EBPa) and C\/EBPa myeloid oncoproteins induce Bcl-2 via interaction of their basic regions with nuclear factor-kB p50. Mol Cancer Res2005; 3:585\u2013596.","DOI":"10.1158\/1541-7786.MCR-05-0111"},{"key":"2019111712350548400_B58","doi-asserted-by":"crossref","unstructured":"Rowland BD, Bernards R, Peeper DS. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol2005; 7:1074\u20131082.","DOI":"10.1038\/ncb1314"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/109\/8\/3451\/1291540\/zh800807003451.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/109\/8\/3451\/1291540\/zh800807003451.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T23:53:53Z","timestamp":1683676433000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/109\/8\/3451\/23751\/Five-members-of-the-CEBP-transcription-factor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,14]]},"references-count":58,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2006,12,14]]},"published-print":{"date-parts":[[2007,4,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2006-08-041012","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,14]]}}}